Adagrasib

(Synonyms: MRTX849)
63 Cited Publications
고객리뷰

Based on 63 publication(s) in Google Scholar

Adagrasib (MRTX849) is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. Adagrasib covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP-bound conformation, and inhibits KRAS-dependent signal transduction.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.96%
  • CAS No.: 2326521-71-3
  • 화학식: C32H35ClFN7O2
  • 분자량:604.12
  • 보관:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) Adagrasib

More
Customer Validation & Images
WBIF
  • WB
  • WB
  • IF
  • WB

All Ras Isoforms

More
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00